The Conscious Fund

The Conscious Fund is a venture capital firm established in 2019 and located in Lewes, Delaware. The firm focuses on investing in early-stage companies within the psychedelics medicine sector, particularly those that emphasize plant-powered therapeutic solutions. By targeting innovative ventures in this emerging field, The Conscious Fund aims to support the development of sustainable and effective treatments that leverage the potential of psychedelics for mental health and wellness.

Michael Hoyos

Co-Founding Partner

Henri Sant-Cassia

Co-Founding Partner

5 past transactions

KEIPhone

Pre Seed Round in 2022
KEIPhone aims to bridge the digital divide in sub-Saharan Africa by offering free smartphones and data to the 70% of the population that lacks internet access. The company is pioneering revenue generation through lock screen advertising, making it the first of its kind in the region. In addition to smartphones, KEIPhone provides solar chargers, which help ensure that users can keep their devices powered. The company’s products deliver content in local languages through various formats, such as video and SMS, and focus on closing the gender gap in internet access. By enhancing connectivity, KEIPhone empowers women and supports their ability to improve their lives through better access to information and resources.

Maya Health

Seed Round in 2021
Naitur.ai is a company focused on enhancing psychedelic healthcare through a specialized practice management platform. Founded in 2019 and based in Denver, Colorado, the platform allows practitioners to track, manage, and measure health outcomes effectively. It offers personalized protocols and psychedelic-specific assessments that help in monitoring dosages, wellness outcomes, and psychological metrics. By streamlining these processes, Naitur.ai aims to reduce the workload for psychedelic practitioners, enabling them to serve a larger number of clients and improve mental health and well-being in the communities they support.

MycroDose Therapeutics

Seed Round in 2021
MycroDose Therapeutics is a U.S.-based pharmaceutical company focused on developing advanced drug delivery systems that utilize psychedelic compounds for the treatment of mental health disorders and cognitive degenerative diseases. The company is actively working on two of its four core technologies, which include a psilocybin transdermal delivery system and a ketamine oral mucosa delivery system. By leveraging these innovative approaches, MycroDose Therapeutics aims to enhance the efficacy and accessibility of treatments for patients dealing with these challenging conditions.

HIVE BIO

Seed Round in 2021
We develop next-generation mental health care protocols and the tools needed to deliver safer access to life-changing therapies for the millions who need them. We are opening a network of residential clinics using psychedelic-assisted psychotherapy.

WeSana Health

Convertible Note in 2021
WeSana Health is a life sciences company that provides advancement of psilocybin-based medicine. The company was founded in 2020 by Daniel Carcillo and is headquartered in Homer Glen, Illinois, United States.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.